Castle Biosciences, Inc. (CSTL)
NASDAQ: CSTL · Real-Time Price · USD
19.94
-0.16 (-0.80%)
At close: Mar 28, 2025, 4:00 PM
20.54
+0.60 (3.02%)
After-hours: Mar 28, 2025, 5:30 PM EDT
Castle Biosciences Employees
Castle Biosciences had 761 employees as of December 31, 2024. The number of employees increased by 151 or 24.75% compared to the previous year.
Employees
761
Change (1Y)
151
Growth (1Y)
24.75%
Revenue / Employee
$436,359
Profits / Employee
$23,975
Market Cap
568.57M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
CSTL News
- 2 days ago - Castle Biosciences' DecisionDx®-SCC Data Earns Top Five Abstract at NCCN 2025, Shows Significantly Enhanced Risk Stratification Beyond Current Staging Within NCCN Risk Groups - GlobeNewsWire
- 23 days ago - New Data to be Presented at the 2025 American Academy of Dermatology (AAD) Annual Meeting Further Strengthens Evidence Supporting the Clinical Value of Castle Biosciences' Dermatology Portfolio - Business Wire
- 4 weeks ago - Castle Biosciences, Inc. (CSTL) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Castle Biosciences Reports Fourth Quarter and Full-Year 2024 Results - Business Wire
- 4 weeks ago - Castle Biosciences to Participate in Upcoming Investor Conferences - Business Wire
- 6 weeks ago - Castle Biosciences to Share Data Reinforcing the Clinical Value of Its Dermatologic Portfolio of Gene Expression Profile Tests at the 22nd Annual Winter Clinical Dermatology Conference - Hawaii® - Business Wire
- 7 weeks ago - Castle Biosciences to Release Fourth Quarter and Full-Year 2024 Financial Results and Host Conference Call on Thursday, Feb. 27, 2025 - Business Wire
- 2 months ago - Castle's Poster on DecisionDx®-SCC Selected as a “Late Breakers” Top Five Finalist for the Akamai Award, Recognizing the Best Posters at Maui Derm Hawaii 2025 - Business Wire